Navigation Links
Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
Date:3/20/2008

- EPOC Results Published in March 22 Issue of The Lancet -

BRIDGEWATER, N.J., March 20 /PRNewswire-FirstCall/ -- Sanofi-aventis today announced that efficacy results of the randomized phase III EORTC 40983 Intergroup study published in the March 22 issue of The Lancet showed that in eligible patients Eloxatin(R) (oxaliplatin injection) in combination with 5-fluorouracil/leucovorin (5-FU/LV), a chemotherapy regimen called FOLFOX4, significantly improved three-year PFS (Progression-Free Survival) compared to surgery alone when given perioperatively (before and after surgery) to colorectal cancer patients with initially resectable liver metastases. PFS is the time from randomization until disease progression/recurrence or death. The EORTC 40983 Intergroup study is also referred to as the EPOC (Eloxatin(R) for Peri-Operative Use) trial.

Among the 342 eligible patients treated in the EPOC study, perioperative FOLFOX4 chemotherapy and surgery significantly improved PFS by 8.1% (from 28.1% to 36.2%) versus surgery alone (Hazard Ratio (HR) of 0.77; Confidence Interval (CI): 0.60-1.00; p=0.041). Among patients who were also able to undergo resection of the liver metastases, post-entry (n=303), perioperative FOLFOX4 significantly improved PFS by 9.2% (from 33.2% to 42.4%) compared with surgery alone (HR=0.73 (CI: 0.55-0.97, p=0.025)).

"Seventy-five percent of patients relapse after liver metastases have been surgically removed. We found that the investigational use of perioperative FOLFOX4 reduces the risk of relapse by one fourth over surgery alone," said principal investigator Professor Bernard Nordlinger, past chairman of the EORTC GI group, chair of the Department of Surgery and Oncology, Hospital Ambroise Pare, Assistance Publique-Hopitaux de Paris, Boulogne, France. "EPOC is the first randomized phase III clinical trial to demonstrate three-year PFS of perioperative FOLFOX4 in eligible metastatic colorectal patients with initially resect
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
4. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
5. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
6. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
7. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
8. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
9. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... and VIENNA, Va. , Nov. ... care provider that operates in Southern California ... provider of remote caregiving technology. Alta will be providing ... client receiving homecare services. Logo - ... is the key to providing the kind of affordable ...
(Date:11/21/2014)... 21, 2014  Heated dialogue in recent months about ... cancer treatments to Gilead,s new hepatitis C drug Harvoni® ... world questioning what it means to put a price ... And while drug pricing is one of the ... both a general business and ethical standpoint – it ...
(Date:11/21/2014)... MELVILLE, N.Y. , Nov. 21, 2014 ... one of the world,s largest health care services companies, ... the world,s largest provider of health care products and ... today announced that the companies have entered into a ... comprehensive service and product offerings to office-based medical practices.  ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5
... 500 employees from Astellas Pharma US, Inc. (Astellas Pharma ... (Astellas) will fan out from company headquarters in Deerfield ... in the City of Chicago and Lake County as ... corporate service commitment.  They join more than 600 other ...
... COPENHAGEN, Denmark, Sept. 22, 2011 CMC Biologics ... manufacturing facility, known as PF2, with a ribbon ... Bothell, Washington campus. The expansion of PF2 duplicates ... business leaders attended the event. (Photo: ...
Cached Medicine Technology:Seven Chicago Area Service Projects Top Off Changing Tomorrow Day at Astellas 2Seven Chicago Area Service Projects Top Off Changing Tomorrow Day at Astellas 3Director of Commerce, Rogers Weed, Presided Over Ribbon Cutting Ceremony Celebrating Opening of Expanded Manufacturing Facility at CMC Biologics 2
(Date:11/22/2014)... (HealthDay News) -- The wide variety and complexity of ... for people with food allergies, an expert warns. ... types of food allergies that it can be really ... Guha Krishnaswamy, director of allergy and clinical immunology at ... news release. "If you know you have food ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Hastings and ... decades of experience announces providing clients with the option ... firm offers clients a flexible, intuitive and easy to ... with having access to Google + allows clients to ... to make a more informed decision when retaining an ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... 2014 Wright & Schulte LLC reports ... have been scheduled between October 2016 and April ... Illinois. U.S. District Judge Matthew F. Kennelly, who is ... Order (CMO) on November 6, 2014 that outlined the ... submit documents and other activities in preparation for the ...
(Date:11/22/2014)... Nov. 21, 2014 (HealthDay News) -- Those air-blown hand ... than conventional paper towels, a new study suggests. ... the hands of volunteers in order to simulate poorly ... high-powered "jet-air" dryers or paper towels to dry their ... found higher amounts of germs around both types of ...
Breaking Medicine News(10 mins):Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Restroom Hand Dryers Spread More Germs Than Paper Towels, Study Finds 2
... slowed reduction of brain size, improved motor functioning, ... -- An experimental compound called HDACi 4b reversed ... develop the disease, say researchers at the Scripps ... an inherited neurological disease that affects people,s movement ...
... in Hospitals, CHICAGO, Sept. 16 Lieutenant Governor ... increase the,number of nurses at the bedside in Illinois ... Network, a statewide organization of nurses,Quinn called on Illinois ... estimates that medical errors cause as many as 195,000 ...
... 16 Particle Sciences, Inc.,announces the issuing of ... the density of sintered metal products. The technology ... way that decreases needed,injection forces, decreases lubricant requirements ... on a proprietary coating,applied to the powders prior ...
... had a twenty-five percent increase in the number of air ambulance ... ... Scottsdale, AZ (PRWEB) September 16, 2008 -- Angel MedFlight ... increase in the number of air ambulance flights they operated in ...
... . Montreal, September 16, 2008 Young ... birds and bees with their parents they need to ... older boys. A new study by researchers from the Universit ... published in the journal Child Development , has found ...
... 15 (Nasdaq: WHRT ),World Heart Corporation ... a review by a NASDAQ Listing Qualifications Panel,NASDAQ ... to be,listed on The Nasdaq Capital Market. Additionally, ... the NASDAQ stating that the Company has,regained compliance ...
Cached Medicine News:Health News:Compound Reverses Huntington's Symptoms in Mice 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 3Health News:Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films 2Health News:Substantial Second Quarter Surge for Angel MedFlight Worldwide Air Ambulance Services 2Health News:Troubled girls from poor neighborhoods more likely to have sex in early adolescence 2Health News:Troubled girls from poor neighborhoods more likely to have sex in early adolescence 3Health News:WorldHeart Receives Favorable Decision to Continue NASDAQ Listing 2
... Triad Plus PVP-I Scrub swabsticks ... surgical cleanser containing to prevent ... USP solution equivalent to 0.75% ... to kill skin surface pathogens, ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
... Aplicare's Saturated Swabsticks are packaged ... Each 4 inch Swabstick is saturated ... solution. Each package is terminally sterilized, ... the patient. Povidone Iodine Scrub is ...
Medicine Products: